Charles River Laboratories International Inc

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Life Sciences Tools & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  12431.6

• Ticker

  CRL.N

• ISIN

  US1598641074

• IPO date

  2000-06-23

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-14

• Date fact. publication of reports

  2023-12-30

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.